Optimization of a Multi-Feature AI Ensemble and Voting System for MAPKAPK2 Inhibitor Discovery
Chen, H.
Show abstract
1.The identification of an effective inhibitor is an essential starting point in drug discovery. Unfortunately, many issues arise with conventional high-throughput screening methods. Thus, new strategies are needed to filter through large compound screening libraries to create target-focused, smaller libraries. Effective computational methods in this respect have emerged in the past decade or so; among these methods is machine learning. Herein, we explore an ensemble Deep Learning model trained on MAPKAPK2 bioactivity data. This ensemble ML model consists of ten individual models trained on different features, each optimized for MAPKAPK2 inhibitor identification. Voting systems were established alongside the model. Using these voting systems, the ensemble model achieved an accuracy score of 0.969 and precision score of 0.964 on a testing set, in addition to reporting a false positive rate of 0.014 on an inactive compound set. The reported metrics indicate an effective initial step for novel MAPKAPK2 inhibitor identification and subsequent drug development, with applicability to other kinase targets.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Deep learning based predictive modeling to screen natural compounds against TNF-alpha for the potential management of Rheumatoid Arthritis: Virtual screening to comprehensive in silico investigation 97%
- PharmaNet: Pharmaceutical discovery with deep recurrent neural networks. 97%
- Identification of Natural Antiviral Drug Candidates Against Tilapia Lake Virus: Computational Drug Design Approaches 96%
Similar papers in this journal
- Retro Drug Design: From Target Properties to Molecular Structures 96%
- Advancements in Ligand-Based Virtual Screening through the Synergistic Integration of Graph Neural Networks and Expert-Crafted Descriptors 96%
- Benchmarking of Small Molecule Feature Representations for hERG, Nav1.5, and Cav1.2 Cardiotoxicity Prediction 96%
Similar papers in this journal
- DenovoProfiling: a webserver for de novo generated molecule library profiling 96%
- Drug repositoning or target repositioning: a structural perspective of drug-target-indication relationship for available repurposed drugs. 95%
- Intense bitterness of molecules: machine learning for expediting drug discovery 95%
Similar papers in this journal
- Utilizing Heteroatom Types and Numbers from Extensive Ligand Libraries to Develop Novel hERG Blocker QSAR Models Using Machine Learning-based Classifiers 98%
- Support Vector Machine based prediction models for drug repurposing and designing novel drugs for colorectal cancer 97%
- Machine learning approaches identify chemical features for stage-specific antimalarial compounds 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.